STAT3 and glioblastoma: Herein, we designed lipid‐polymer hybrid nanoparticles by a combinational assembly strategy for compartmentalized Cas9‐ and STAT3‐targeting sgRNA (sgSTAT3) delivery to knock out STAT3 for tumor vessel normalization and immunostimulatory reprogramming in glioblastoma (Scheme1).